Compare, Analyse Aurobindo Pharma with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results

AUROBINDO PHARMA     Change

Aurobindo Pharma is one of India's top 5 pharma companies in terms of turnover, and has presence in the generic and Active Pharmaceutical Ingredients (API) segments. The company's robust product portfolio is spread across 6 product areas, including a... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 AUROBINDO PHARMA   ADCOCK INGRAM
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-19
ADCOCK INGRAM
Jun-14
AUROBINDO PHARMA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs830376-   
Low Rs527271-   
Sales per share (Unadj.) Rs333.9111.7-  
Earnings per share (Unadj.) Rs40.4-28.1-  
Cash flow per share (Unadj.) Rs51.8-23.3-  
Dividends per share (Unadj.) Rs2.500-  
Dividend yield (eoy) %0.40-  
Book value per share (Unadj.) Rs237.187.7-  
Shares outstanding (eoy) m585.91168.78-   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.02.9 70.2%   
Avg P/E ratio x16.8-11.5 -146.4%  
P/CF ratio (eoy) x13.1-13.9 -94.6%  
Price / Book Value ratio x2.93.7 77.6%  
Dividend payout %6.20-   
Avg Mkt Cap Rs m397,56954,555 728.7%   
No. of employees `00017.94.3 415.9%   
Total wages/salary Rs m25,8493,424 754.9%   
Avg. sales/employee Rs Th10,956.94,392.1 249.5%   
Avg. wages/employee Rs Th1,447.7797.6 181.5%   
Avg. net profit/employee Rs Th1,324.3-1,106.7 -119.7%   
INCOME DATA
Net Sales Rs m195,63618,855 1,037.6%  
Other income Rs m1,553132 1,176.3%   
Total revenues Rs m197,18918,987 1,038.5%   
Gross profit Rs m39,519-3,267 -1,209.5%  
Depreciation Rs m6,680814 820.8%   
Interest Rs m2,626511 514.1%   
Profit before tax Rs m31,767-4,460 -712.3%   
Minority Interest Rs m27-12 -217.2%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-8810-   
Tax Rs m7,269279 2,608.2%   
Profit after tax Rs m23,645-4,751 -497.7%  
Gross profit margin %20.2-17.3 -116.6%  
Effective tax rate %22.9-6.2 -366.2%   
Net profit margin %12.1-25.2 -48.0%  
BALANCE SHEET DATA
Current assets Rs m153,64513,810 1,112.6%   
Current liabilities Rs m120,4297,770 1,549.9%   
Net working cap to sales %17.032.0 53.0%  
Current ratio x1.31.8 71.8%  
Inventory Days Days135111 121.9%  
Debtors Days Days64124 51.4%  
Net fixed assets Rs m103,9098,050 1,290.8%   
Share capital Rs m58688 669.3%   
"Free" reserves Rs m138,3220-   
Net worth Rs m138,90814,799 938.6%   
Long term debt Rs m1,8005,201 34.6%   
Total assets Rs m264,54427,957 946.3%  
Interest coverage x13.1-7.7 -169.4%   
Debt to equity ratio x00.4 3.7%  
Sales to assets ratio x0.70.7 109.7%   
Return on assets %9.9-15.2 -65.5%  
Return on equity %17.0-32.1 -53.0%  
Return on capital %23.8-19.8 -120.3%  
Exports to sales %49.60-   
Imports to sales %18.80-   
Net fx Rs m56,7270-   
CASH FLOW
From Operations Rs m16,2201,609 1,007.8%  
From Investments Rs m-28,768-494 5,821.5%  
From Financial Activity Rs m19,1914,720 406.6%  
Net Cashflow Rs m6,6565,835 114.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.18 Rs / ZAR

Compare AUROBINDO PHARMA With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare AUROBINDO PHARMA With: PFIZER  JUBILANT PHARMOVA   FDC  NATCO PHARMA  SUN PHARMA  



Today's Market

Sensex Ends 257 Points Higher; Tata Steel & Hindalco Among Top Nifty Gainers(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended higher.

Related Views On News

AUROBINDO PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 25.6% (Quarterly Result Update)

Sep 15, 2020 | Updated on Sep 15, 2020

For the quarter ended June 2020, AUROBINDO PHARMA has posted a net profit of Rs 8 bn (up 25.6% YoY). Sales on the other hand came in at Rs 59 bn (up 8.8% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA Announces Quarterly Results (4QFY20); Net Profit Up 48.2% (Quarterly Result Update)

Jun 5, 2020 | Updated on Jun 5, 2020

For the quarter ended March 2020, AUROBINDO PHARMA has posted a net profit of Rs 9 bn (up 48.2% YoY). Sales on the other hand came in at Rs 62 bn (up 16.4% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

Why Did Alembic Pharma Shares Fall Today? (Views On News)

May 5, 2021

Covid-led supply disruptions of API fuel Alembic Pharma's global prospects.

AUROBINDO PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Nov 6, 2019 | Updated on Nov 6, 2019

Here's an analysis of the annual report of AUROBINDO PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of AUROBINDO PHARMA. Also includes updates on the valuation of AUROBINDO PHARMA.

More Views on News

Most Popular

Time to Buy Smallcaps? (Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

The Next Smallcap Winners (Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Sell in May and Go Away? (Fast Profits Daily)

Apr 28, 2021

Does the concept of selling stocks in the month of May, work in the Indian market?

This Fund Manager Has Taken the World by Storm. Will You Invest With Her? (Profit Hunter)

Apr 26, 2021

Should you invest with this Rockstar fund manager who has outperformed in a big way?

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

FREE Event: Discover Your First Stock for a Potential Rs 7 Crore in Long-term Wealth
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

AUROBINDO PHARMA SHARE PRICE


May 7, 2021 (Close)

TRACK AUROBINDO PHARMA

  • Track your investment in AUROBINDO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON AUROBINDO PHARMA

AUROBINDO PHARMA 8-QTR ANALYSIS

COMPARE AUROBINDO PHARMA WITH

FEATURED VIDEOS

The 'Big' Money is in this 'Small' Detail

Stability, Quality or Green Stocks for 2021?

Market Crash: Picture Abhi Baaki Hai?

It's a Great Time to Buy Gold

More Featured Videos

MARKET STATS